Literature DB >> 15715894

Cataracts in experimentally diabetic mouse: morphological and apoptotic changes.

K R Hegde1, S D Varma.   

Abstract

AIM: The objective of these investigations was to extend our earlier study on the induction of cataracts in diabetic mice, a low aldose reductase (AR) animal model at morphological level. Previous studies were done primarily at biochemical level.
METHODS: Diabetes was induced by intraperitoneal administration of streptozotocin. The lenses isolated after the establishment of diabetes were then subjected to histologic and electron microscopic studies.
RESULTS: Morphological alterations were characterized by shrinkage, elongation and lobulization of the nuclei of the epithelial cells. This was associated with chromatin condensation and its margination. Similar structural aberrations were also observed in a significant number of the subepithelial fibre cells representing defect in fibre maturation. More interestingly, unlike that in other common animal models of diabetic cataract, such abnormally nucleated cells were also found to be prevalent in the posterior subcapsular region, a finding common in human diabetics also.
CONCLUSION: The present studies further affirm the suitability of the mouse model for a study of cataractogenesis induced by diabetes. Because of the findings reported herein, as well as the known biochemical similarity between the lenses of the mice and humans in respect of AR deficiency, contrary to the rat model where it is very high, use of this species is considered more useful towards understanding the basic aetiology as well as for evaluating the efficacy of various referred nutritional and metabolic antioxidants against such cataracts.

Entities:  

Mesh:

Year:  2005        PMID: 15715894     DOI: 10.1111/j.1463-1326.2004.00368.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  8 in total

1.  Expression and regulation of microRNA-29a and microRNA-29c in early diabetic rat cataract formation.

Authors:  Ying Sun; Chun-Mei Lu; Zhen Song; Ke-Ke Xu; Shu-Bin Wu; Zhi-Jian Li
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

2.  Prevention of cataract by pyruvate in experimentally diabetic mice.

Authors:  K R Hegde; S D Varma
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

3.  Upregulation of glyoxalase I fails to normalize methylglyoxal levels: a possible mechanism for biochemical changes in diabetic mouse lenses.

Authors:  Magdalena M Staniszewska; Ram H Nagaraj
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

4.  Effect of high sugar levels on miRNA expression. Studies with galactosemic mice lenses.

Authors:  Shambhu D Varma; Svitlana Kovtun; Kavita Hegde; Jing Yin; Jamuna Ramnath
Journal:  Mol Vis       Date:  2012-06-17       Impact factor: 2.367

5.  Low glucose under hypoxic conditions induces unfolded protein response and produces reactive oxygen species in lens epithelial cells.

Authors:  R Elanchezhian; P Palsamy; C J Madson; M L Mulhern; D W Lynch; A M Troia; J Usukura; T Shinohara
Journal:  Cell Death Dis       Date:  2012-04-19       Impact factor: 8.469

6.  Regulation of transforming growth factor β-mediated epithelial-mesenchymal transition of lens epithelial cells by c-Src kinase under high glucose conditions.

Authors:  Zhi-Hua Han; Fang Wang; Fu-Lei Wang; Qi Liu; Jian Zhou
Journal:  Exp Ther Med       Date:  2018-06-22       Impact factor: 2.751

7.  LncRNA MALAT1 Regulates miR-144-3p to Facilitate Epithelial-Mesenchymal Transition of Lens Epithelial Cells via the ROS/NRF2/Notch1/Snail Pathway.

Authors:  Wei Ye; Jiyuan Ma; Fang Wang; Tong Wu; Mengmei He; Ji Li; Rui Pei; Luning Zhang; Yafen Wang; Jian Zhou
Journal:  Oxid Med Cell Longev       Date:  2020-11-12       Impact factor: 6.543

8.  Sulforaphane-induced transcription of thioredoxin reductase in lens: possible significance against cataract formation.

Authors:  Shambhu D Varma; Krish Chandrasekaran; Svitlana Kovtun
Journal:  Clin Ophthalmol       Date:  2013-10-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.